Retatrutide is a novel triple agonist that simultaneously targets the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon (GCGR) receptors. By activating these three key receptors, Retatrutide exerts a powerful and synergistic effect on metabolic regulation. It enhances insulin secretion, reduces appetite, promotes fat metabolism, and increases energy expenditure. This multi-receptor action leads to significant improvements in both blood glucose control and body weight reduction. Clinical trials have shown that Retatrutide can lead to substantial weight loss and improved glycemic control, making it a promising therapeutic candidate for obesity and type 2 diabetes. As a synthetic peptide administered via weekly subcutaneous injection.
| Product Name | Retatrutide Peptide |
| Shelf Life | 2 Years |
| Form | Peptide |
| Indication | Weight Loss |
| Dosage | 1mg~12mg/week |
| Active Ingredient | Retatrutide |
| Storage Conditions | Store At 2-25°C |
| Packaging | 10mg/vial, 15mg/vial, 20mg/vial, 30mg/vial, 40mg/vial |
Retatrutide is a triple hormone receptor agonist that targets GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and GCGR (glucagon receptor). Its primary function is to regulate metabolism and support the treatment of obesity and type 2 diabetes. Here's how it works:
1. Improves Blood Glucose Control:
– Stimulates insulin secretion in a glucose-dependent manner.
– Reduces glucagon levels when blood sugar is high.
2. Suppresses Appetite:
– Acts on the brain’s appetite centers to reduce hunger and increase satiety.
3. Enhances Energy Expenditure:
– Activation of the glucagon receptor promotes calorie burning and fat metabolism.
4. Promotes Significant Weight Loss:
– By combining these effects, Retatrutide helps reduce body weight more effectively than single or dual agonists.
For high value products, please select air shipping and express delivery for safety.
